Ligand Pharmaceuticals (LGND) EPS (Basic) (2010 - 2026)
Ligand Pharmaceuticals (LGND) reported EPS (Basic) of -$0.67 for Q1 2026, up 69.66% on a YoY basis from -$0.4 in Q1 2025, and down 128.98% sequentially from $2.32 in Q4 2025.
Ligand Pharmaceuticals (LGND) EPS (Basic) (2010 - 2026) Analysis & Trends
Ligand Pharmaceuticals (LGND) has 15 years of EPS (Basic) data on file, last reported at -$0.67 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 69.66% year-over-year to -$0.67; the trailing twelve-month figure through Mar 2026 stood at $7.72 (up 301.55% YoY), and the FY2025 full-year result was $6.44, up 3019.36% from the prior year.
- EPS (Basic) declined to -$0.67 in Q1 2026, from $2.32 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $5.99 in Q3 2025 to a low of -$2.21 in Q1 2025.
- A 5-year average of $0.2 and a median of -$0.17 in 2022 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) sank 133.11% in 2022 and surged 236.25% in 2025, its largest moves.
- Tracing LGND's EPS (Basic) over 5 years: stood at -$0.17 in 2022, then jumped by 44.22% to -$0.1 in 2023, then tumbled by 1641.89% to -$1.7 in 2024, then surged by 236.25% to $2.32 in 2025, then slumped by 128.98% to -$0.67 in 2026.
- Business Quant data shows LGND's EPS (Basic) at -$0.67 in Q1 2026, $2.32 in Q4 2025, and $5.99 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Ligand Pharmaceuticals | 5.96 Bn | 5.18 Bn | 48.45 Mn | -0.67 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.67 |
| Dec 31, 2025 | 2.32 |
| Sep 30, 2025 | 5.99 |
| Jun 30, 2025 | 0.25 |
| Mar 31, 2025 | -2.21 |
| Dec 31, 2024 | -1.70 |
| Mar 31, 2023 | -0.10 |
| Dec 31, 2022 | -0.17 |
| Sep 30, 2022 | -0.55 |
| Jun 30, 2022 | -0.80 |
| Mar 31, 2022 | -0.15 |
| Dec 31, 2021 | -0.13 |
| Sep 30, 2021 | -0.40 |
| Jun 30, 2021 | -0.34 |
| Mar 31, 2021 | -0.28 |
| Dec 31, 2020 | 1.09 |
| Sep 30, 2020 | -0.42 |
| Jun 30, 2020 | 1.38 |
| Mar 31, 2020 | -1.46 |
| Dec 31, 2019 | -0.39 |